V

VYNE Therapeutics
D

VYNE

0.37220
USD
0.05
(14.45%)
مغلق
حجم التداول
52,587
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
9,480,740
أصول ذات صلة الأخبار المقالات

العنوان: VYNE Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.